Product Description.

Novorapid 100IU/ml Flexpen 3 ml is a rapid-acting human insulin analogue for the treatment of diabetes mellitus in both children (above two years of age) and adults. The active ingredient in Novorapid 100IU/ml Flexpen 3 ml is insulin aspart. Diabetes is a medical condition where your body does not produce enough insulin to control your blood sugar level. Treatment with Novorapid 100IU/ml Flexpen 3 ml helps to prevent complications from your diabetes.

Dosage.

Novorapid 100IU/ml Flexpen 3 ml is administered 5-10 minutes before taking meal subcutaneously (SC) in the abdomen or thigh region. It can be also given intravenously (IV) with 0.9% sodium chloride infusion. However subcutaneous injection of Novorapid 100IU/ml Flexpen 3 ml in the abdomen region ensures faster absorption compared to other injection sites. Novorapid 100IU/ml Flexpen 3 ml is usually given once or twice daily when both rapid and prolonged effect of insulin is desired. In the initial requirement, the dose requirement is usually between 0.3 and 1.0 IU/kg per day. An injection of Novorapid 100IU/ml Flexpen 3 ml should be followed within 30 minutes by a meal or snack containing sugar/glucose (carbohydrates).

Side Effects.

• Hypokalaemia (low potassium)
• Hypoglycaemia (low blood sugar level)
• Local injection site reactions
• Lipodystrophy (fat deposition under the skin)
• Rash
• Pruritus (itchy skin)